Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Praram 9 Hospital PCLBKK:PR9 -0.54%90 Debt-to-EBITDA is 0.01 as of Mar. 2026, which is at its 10-year median of 0.01. GuruFocus rates BKK:PR9 with a GF Score™ of 90/100 and a GF Value™ of ฿23.90 (Modestly Undervalued). Among 476 Healthcare Providers & Services companies, Praram 9 Hospital PCL ranks better than 99.79% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Praram 9 Hospital PCL's Debt-to-EBITDA or its related term are showing as below:
BKK:PR9'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0 Med: 0.01 Max: 0.02
Current: 0.01
During the past 12 years, the highest Debt-to-EBITDA Ratio of Praram 9 Hospital PCL was 0.02. The lowest was 0.00. And the median was 0.01.
BKK:PR9's Debt-to-EBITDA is ranked better than 99.79% of 476
companies
in the Healthcare Providers & Services industry
Industry Median: 2.18
vs BKK:PR9: 0.01
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Praram 9 Hospital PCL Debt-to-EBITDA Related Terms
Praram 9 Hospital PCL Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for Praram 9 Hospital PCL's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BKK:PR9 vs HCA, THC, DVA: Debt-to-EBITDA Comparison
For the Medical Care Facilities subindustry, Praram 9 Hospital PCL's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Praram 9 Hospital PCL Debt-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Praram 9 Hospital PCL's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Praram 9 Hospital PCL's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Mar. 2026) EBITDA data.
Praram 9 Hospital PCL (BKK:PR9) has a Debt-to-EBITDA of 0.01 as of Mar. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Praram 9 Hospital PCL. This is near median its historical median of 0.01. According to the industry distribution chart, Praram 9 Hospital PCL ranks #1 out of 476 companies in the Healthcare Providers & Services industry, placing it in the top 0.2%.
Is Praram 9 Hospital PCL's Debt-to-EBITDA too high?
Praram 9 Hospital PCL's current Debt-to-EBITDA of 0.01 is near median its 10-year median of 0.01. The Healthcare Providers & Services industry median Debt-to-EBITDA is 2.18. Praram 9 Hospital PCL's value of 0.01 is 99.5% below this industry median. Based on the distribution chart, Praram 9 Hospital PCL ranks #1 out of 476 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Praram 9 Hospital PCL has a GF Score™ of 90/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Praram 9 Hospital PCL's Debt-to-EBITDA compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Praram 9 Hospital PCL ranks #1 out of 476 companies for Debt-to-EBITDA. This places Praram 9 Hospital PCL in the top 0% of its industry — outperforming the majority of peers. The industry median Debt-to-EBITDA is 2.18. Praram 9 Hospital PCL's value of 0.01 is 99.5% below this benchmark. While the company's 10-year median is 0.01 vs. the industry median of 2.18, Praram 9 Hospital PCL has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Healthcare Providers & Services company?
The median Debt-to-EBITDA among Healthcare Providers & Services companies is 2.18, based on 476 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Praram 9 Hospital PCL's current Debt-to-EBITDA of 0.01 is 99.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Praram 9 Hospital PCL. For the Healthcare Providers & Services industry, the median Debt-to-EBITDA is 2.18 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Praram 9 Hospital PCL's current Debt-to-EBITDA is 0.01, which is near median its own 10-year median of 0.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Praram 9 Hospital PCL stock overvalued right now?
Based on GuruFocus' analysis, Praram 9 Hospital PCL (BKK:PR9) is currently considered Modestly Undervalued. The stock's GF Value™ is ฿23.90, compared to a current price of ฿18.50 — trading 22.6% below its estimated fair value. The current Debt-to-EBITDA is 0.01, which is near median its 10-year median of 0.01 and 99.5% below the Healthcare Providers & Services industry median of 2.18. Praram 9 Hospital PCL's overall GF Score™ is 90/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Praram 9 Hospital PCL (BKK:PR9), the current Debt-to-EBITDA is 0.01 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Praram 9 Hospital PCL (BKK:PR9) Overvalued in 2026?
Based on GuruFocus' analysis, Praram 9 Hospital PCL stock appears to be undervalued.
The current stock price of ฿18.50 is trading 22.6% below its estimated GF Value™ of ฿23.90.
GuruFocus considers Praram 9 Hospital PCL to be Modestly Undervalued.
Key valuation signals for BKK:PR9:
Debt-to-EBITDA: 0.01 (near median its 10-year median of 0.01)
GF Value™: ฿23.90 vs. price of ฿18.50 (22.6% below fair value)
Industry Position: 99.5% below the Healthcare Providers & Services median (#1 of 476)
No single metric tells the full story. See the BKK:PR9 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Praram 9 Hospital PCL is engaged in hospital operations in Bangkok. The company operates an overnight general hospital under the name of Praram 9 Hospital. The revenue derived from hospital operations mainly consists of medical fees, hospital room sales, and medicine sales. Geographically, the company operates only in Thailand.
90GF Score
Get the complete analysis for BKK:PR9
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:PR9 has been successfully added to your 
